cysteine protease inhibitor (Boehringer Ingelheim)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecysteine protease inhibitor (Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin B inhibitors
TargetsCathepsin B
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A